339 related articles for article (PubMed ID: 11696595)
1. The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors.
Akari H; Bour S; Kao S; Adachi A; Strebel K
J Exp Med; 2001 Nov; 194(9):1299-311. PubMed ID: 11696595
[TBL] [Abstract][Full Text] [Related]
2. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.
Bour S; Perrin C; Akari H; Strebel K
J Biol Chem; 2001 May; 276(19):15920-8. PubMed ID: 11278695
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of β-TrcP-dependent ubiquitination of p53 by HIV-1 Vpu promotes p53-mediated apoptosis in human T cells.
Verma S; Ali A; Arora S; Banerjea AC
Blood; 2011 Jun; 117(24):6600-7. PubMed ID: 21521785
[TBL] [Abstract][Full Text] [Related]
4. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.
Douglas JL; Viswanathan K; McCarroll MN; Gustin JK; Früh K; Moses AV
J Virol; 2009 Aug; 83(16):7931-47. PubMed ID: 19515779
[TBL] [Abstract][Full Text] [Related]
5. HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.
Manganaro L; de Castro E; Maestre AM; Olivieri K; García-Sastre A; Fernandez-Sesma A; Simon V
J Virol; 2015 Oct; 89(19):9781-90. PubMed ID: 26178989
[TBL] [Abstract][Full Text] [Related]
6. βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin.
Song YE; Cyburt D; Lucas TM; Gregory DA; Lyddon TD; Johnson MC
Viruses; 2018 Oct; 10(10):. PubMed ID: 30347660
[TBL] [Abstract][Full Text] [Related]
7. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.
Margottin F; Bour SP; Durand H; Selig L; Benichou S; Richard V; Thomas D; Strebel K; Benarous R
Mol Cell; 1998 Mar; 1(4):565-74. PubMed ID: 9660940
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins.
Ramirez PW; DePaula-Silva AB; Szaniawski M; Barker E; Bosque A; Planelles V
Retrovirology; 2015 Jul; 12():65. PubMed ID: 26215564
[TBL] [Abstract][Full Text] [Related]
9. Differential dysregulation of β-TrCP1 and -2 by HIV-1 Vpu leads to inhibition of canonical and non-canonical NF-κB pathways in infected cells.
Pickering S; Sumner J; Kerridge C; Perera M; Neil S
mBio; 2023 Aug; 14(4):e0329322. PubMed ID: 37341489
[TBL] [Abstract][Full Text] [Related]
10. Putative E3 ubiquitin ligase of human rotavirus inhibits NF-κB activation by using molecular mimicry to target β-TrCP.
Morelli M; Dennis AF; Patton JT
mBio; 2015 Jan; 6(1):. PubMed ID: 25626907
[TBL] [Abstract][Full Text] [Related]
11. β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release.
Tervo HM; Homann S; Ambiel I; Fritz JV; Fackler OT; Keppler OT
Retrovirology; 2011 Feb; 8():9. PubMed ID: 21310048
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4
Sugden SM; Pham TNQ; Cohen ÉA
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148794
[TBL] [Abstract][Full Text] [Related]
13. Structural studies on 24P-IkappaBalpha peptide derived from a human IkappaB-alpha protein related to the inhibition of the activity of the transcription factor NF-kappaB.
Pons J; Evrard-Todeschi N; Bertho G; Gharbi-Benarous J; Sonois V; Benarous R; Girault JP
Biochemistry; 2007 Mar; 46(11):2958-72. PubMed ID: 17319651
[TBL] [Abstract][Full Text] [Related]
14. NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP.
Coadou G; Gharbi-Benarous J; Megy S; Bertho G; Evrard-Todeschi N; Segeral E; Benarous R; Girault JP
Biochemistry; 2003 Dec; 42(50):14741-51. PubMed ID: 14674748
[TBL] [Abstract][Full Text] [Related]
15. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Vpu sequesters beta-transducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates.
Besnard-Guerin C; Belaïdouni N; Lassot I; Segeral E; Jobart A; Marchal C; Benarous R
J Biol Chem; 2004 Jan; 279(1):788-95. PubMed ID: 14561767
[TBL] [Abstract][Full Text] [Related]
17. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.
Mitchell RS; Katsura C; Skasko MA; Fitzpatrick K; Lau D; Ruiz A; Stephens EB; Margottin-Goguet F; Benarous R; Guatelli JC
PLoS Pathog; 2009 May; 5(5):e1000450. PubMed ID: 19478868
[TBL] [Abstract][Full Text] [Related]
18. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function.
Raja NU; Jabbar MA
Virology; 1996 Jun; 220(1):141-51. PubMed ID: 8659106
[TBL] [Abstract][Full Text] [Related]
19. The HIV-1 Vpu protein induces apoptosis in Drosophila via activation of JNK signaling.
Marchal C; Vinatier G; Sanial M; Plessis A; Pret AM; Limbourg-Bouchon B; Théodore L; Netter S
PLoS One; 2012; 7(3):e34310. PubMed ID: 22479597
[TBL] [Abstract][Full Text] [Related]
20. The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes.
Khoshnan A; Tindell C; Laux I; Bae D; Bennett B; Nel AE
J Immunol; 2000 Aug; 165(4):1743-54. PubMed ID: 10925251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
